We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Legislation (93)
- Advertising (272)
- COVID-19 (163)
- Safety monitoring and information (96)
- Compliance and enforcement (65)
- Manufacturing (52)
- Vaping hub (51)
- Labelling and packaging (35)
- Scheduling (national classification system) (27)
- Import and export (26)
- Medicinal cannabis hub (25)
- Sunscreens (16)
- Shortages and supply disruptions (14)
- Weight loss products (14)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
144 result(s) found, displaying 76 to 100
-
Regulatory decision noticesA new Therapeutic Goods Determination for listed medicine ingredients commences on 1 March 2022.
-
Regulatory decision noticesA new Therapeutic Goods Determination for listed medicine ingredients commenced on 18 January 2022.
-
News articlesThe new Therapeutic Goods (Medicines Advisory Statements) Specification 2021 commences 1 January 2022
-
Regulatory decision noticesA new Therapeutic Goods Determination for listed medicine ingredients commenced on 25 October 2021.
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
Regulatory decision noticesThe Minamata Convention facilitates a global approach to address concerns relating to mercury, which is persistent, toxic and highly mobile in the environment once released, and recognised as a substance producing significant neurological and other effects in humans.
-
News articlesInformation about how sunscreens are approved for supply in Australia and what you will see on sunscreen labels.
-
Regulatory decision noticesThis instrument is made under subregulations 4A.2(4) of the Therapeutic Goods (Medical Devices) Regulations 2002.
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
Regulatory decision noticesArrangement under subsection 7C(1) of the Therapeutic Goods Act 1989 for use of computer programs to make decisions under sections 41FDB, 41FF and 41FH of the Act
-
News articlesIn Australia, a sports supplement can be classified as either a food or a medicine
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
BlogHow to find information about the inactive ingredients in your medicines.
-
Regulatory decision noticesListed medicine ingredients and requirements have been updated.
-
Regulatory decision noticesA new S41BD(3) instrument has been signed to declare that some nappy rash products are not to be medical devices for the purposes of the Act
-
Regulatory decision noticesThe Permissible Ingredients Determination has been updated.
-
Regulatory decision noticesThe Permissible Ingredients Determination has been updated.
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Indications) Determination has been updated
-
Regulatory decision noticesTherapeutic Goods (Declared Goods) Order 2019 consolidates and replaces several instruments
-
Regulatory decision noticesAn amendment to the Therapeutic Goods (Permissible Ingredients) Determination commenced on 2 September 2019.
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
Regulatory decision noticesTGO 100 has been registered on the Federal Register of Legislation. It commences on 8 December 2018, repealing and replacing TGO 98
-
Regulatory decision noticesThis instrument applies to an application to list a complementary medicine under section 26AE of the Act.